Qiagen is a holding company. Through its subsidiaries, Co. is a global provider of Sample to Insight solutions that are used by its customers worldwide to transform biological samples into molecular insights. Co.'s sample technologies are used to isolate and process deoxyribonucleic acid, ribonucleic acid and proteins from blood, tissue and other materials. Assay technologies are used to make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases are used to analyze and interpret genomic data to report relevant, actionable insights. Automation solutions are used to tie these technologies together in workflows. The QGEN stock yearly return is shown above.
The yearly return on the QGEN stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2018 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the QGEN annual return calculation with any dividends reinvested as applicable (on ex-dates).
|